# Randomized, Open Label Trial of 6 Months Versus 12 Months DAPT After Drug-Eluting Stent in STEMI

Study · id `cardio:ct-nct01459627` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01459627](<https://clinicaltrials.gov/study/NCT01459627>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01459627

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 1100 participants.

## Technical summary

Registry record NCT01459627. Randomized; no masking; primary purpose treatment. Start 2011-12 (registry gives no type); primary completion 2017-08 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 1100 participants (planned count; ClinicalTrials.gov record NCT01459627, source copy `cardio:ctgov-nct01459627-2017-09-07`, retrieved 2026-10-26)
- Start date: 2011-12 (registry gives no type) (ClinicalTrials.gov record NCT01459627, source copy `cardio:ctgov-nct01459627-2017-09-07`, retrieved 2026-10-26)
- Primary completion: 2017-08 (actual) (ClinicalTrials.gov record NCT01459627, source copy `cardio:ctgov-nct01459627-2017-09-07`, retrieved 2026-10-26)
- Completion: 2017-08 (actual) (ClinicalTrials.gov record NCT01459627, source copy `cardio:ctgov-nct01459627-2017-09-07`, retrieved 2026-10-26)
- Countries: Netherlands; Norway; Poland; Switzerland (ClinicalTrials.gov record NCT01459627, source copy `cardio:ctgov-nct01459627-2017-09-07`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01459627-2017-09-07`, retrieved 2026-10-26)

## The registry's words

- Brief title: Randomized, Open Label Trial of 6 Months Versus 12 Months DAPT After Drug-Eluting Stent in STEMI
- Acronym: DAPT-STEMI
- Condition: Myocardial Infarction
- Condition: Cardiovascular Disease
- Intervention (Other): 6 months DAPT
- Intervention (Other): 12 months DAPT
- Lead sponsor: Maasstad Hospital
- Lead sponsor class: OTHER
- Collaborator: Medtronic
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry lists this organization as the lead sponsor: Maasstad Hospital (`cardio:org-maasstad-hospital`)
- Registry lists this organization as a collaborator: Medtronic (`cardio:medtronic`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Six months versus 12 months dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction (DAPT-STEMI): randomised, multicentre, non-inferiority trial (`cardio:pubmed-30279197`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Resolute zotarolimus-eluting stent in ST-elevation myocardial infarction (resolute-STEMI): A prespecified prospective register from the DAPT-STEMI trial (`cardio:pubmed-31268629`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: dfb47241d018196814db66df500816da7daa9a7e19e7ca4347ccad3ec46f44e6
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
